Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
22.36
-0.51 (-2.23%)
Aug 31, 2026, 3:00 PM CST

SHA:600196 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
41,82840,97240,39640,91143,37738,666
Other Revenue
760.76689.21671.23488.71574.48345.58
42,58941,66241,06741,40043,95239,011
Revenue Growth
6.16%1.45%-0.80%-5.81%12.66%28.72%
Cost of Revenue
21,03020,87821,42621,71723,25620,294
Gross Profit
21,55920,78419,64119,68320,69618,717
Selling, General & Admin
14,15513,77712,96314,08712,99912,328
Research & Development
4,3834,0133,6444,3464,3023,837
Other Operating Expenses
159.8681.12-47.52-44.99-88.15-57.86
Operating Expenses
18,82417,99316,66818,49917,27516,180
Operating Income
2,7352,7902,9741,1843,4202,537
Interest Expense
-1,220-1,265-1,432-1,325-963.81-822.54
Interest & Investment Income
3,4094,0642,4783,8664,6604,858
Currency Exchange Gain (Loss)
-74.75-152.16-13.3613.0362.36154.63
Other Non Operating Income (Expenses)
20.12-38.46-41.41-57.73-31.78-31.06
EBT Excluding Unusual Items
4,8705,3983,9653,6807,1476,695
Impairment of Goodwill
-----180-150
Gain (Loss) on Sale of Investments
-0.02-362.6-115.94-488.66-2,498-110.19
Gain (Loss) on Sale of Assets
67.4369.35371.015.56125.6-15.42
Asset Writedown
-41.2-41.64-57.93-42.14-20.48-171.01
Other Unusual Items
83.9748.09-5.44109.380.25-206.16
Pretax Income
4,9805,1124,1693,2654,5746,043
Income Tax Expense
683.43864.05656.84369.5626.921,066
Earnings From Continuing Operations
4,2974,2483,5122,8953,9474,976
Minority Interest in Earnings
-906.59-877.37-742.55-508.8-216.66-247.56
Net Income
3,3903,3712,7702,3863,7314,729
Preferred Dividends & Other Adjustments
---1.05--
Net Income to Common
3,3903,3712,7702,3853,7314,729
Net Income Growth
4.40%21.69%16.13%-36.07%-21.10%29.10%
Shares Outstanding (Basic)
2,6412,6462,6702,6702,6072,563
Shares Outstanding (Diluted)
2,6412,6462,6702,6702,6072,563
Shares Change
-1.05%-0.90%0.02%2.40%1.74%-
EPS (Basic)
1.281.271.040.891.431.85
EPS (Diluted)
1.281.271.040.891.431.85
EPS Growth
5.20%22.44%16.10%-37.52%-22.50%29.10%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
699.77764.7866.79-1,922-1,671-1,035
Free Cash Flow Per Share
0.270.290.03-0.72-0.64-0.40
Dividend Per Share
0.3900.3900.3200.2700.4200.560
Dividend Growth
21.88%21.88%18.52%-35.71%-25.00%30.23%
Gross Margin
50.62%49.89%47.83%47.54%47.09%47.98%
Operating Margin
6.42%6.70%7.24%2.86%7.78%6.50%
Profit Margin
7.96%8.09%6.74%5.76%8.49%12.12%
Free Cash Flow Margin
1.64%1.84%0.16%-4.64%-3.80%-2.65%
EBITDA
5,9015,8835,5563,8835,5414,184
EBITDA Margin
13.86%14.12%13.53%9.38%12.61%10.72%
D&A For EBITDA
3,1663,0932,5822,6992,1211,647
EBIT
2,7352,7902,9741,1843,4202,537
EBIT Margin
6.42%6.70%7.24%2.86%7.78%6.50%
Effective Tax Rate
13.72%16.90%15.75%11.32%13.71%17.65%